A Fixed-Dose Combination of Meloxicam and Rizatriptan (Symbravo) for Migraine

被引：0

作者：

不详

机构：

来源：

MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2025年 / 67卷 / 1727期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页数：10

共 9 条

[1] The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice [J].

Ailani, Jessica ;

Burch, Rebecca C. ;

Robbins, Matthew S. .

HEADACHE, 2021, 61 (07) :1021-1039

[2]

[Anonymous], 2023, MED LETT DRUGS THER, V65, P89, DOI 10.58347/tml.2023.1678a

[3]

[Anonymous], 2008, Med Lett Drugs Ther, V50, P45

[4]

[Anonymous], 2025, Axsome Therapeutics News Release

[5]

Jones A, 2020, 2020 AM AC NEUR SCI

[6]

Jones A, 2021, AM HEAD SOC VIRT ANN

[7]

Jones A, 2022, Neurology, V98, P2915

[8] Sumatriptan plus naproxen for the treatment of acute migraine attacks in adults [J].

Law, Simon ;

Derry, Sheena ;

Moore, R. Andrew .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (04)

[9] Comparison of New Pharmacologic Agents With Triptans for Treatment of Migraine A Systematic Review and Meta-analysis [J].

Yang, Chun-Pai ;

Liang, Chih-Sung ;

Chang, Ching-Mao ;

Yang, Cheng-Chia ;

Shih, Po-Hsuan ;

Yau, Yun-Chain ;

Tang, Kuo-Tung ;

Wang, Shuu-Jiun .

JAMA NETWORK OPEN, 2021, 4 (10) :E2128544

← 1 →